The role of odor and verbal cues in recalling memories

UCB’s treat­ment can­di­dates for plaque pso­ri­a­sis and gen­er­al­ized myas­the­nia gravis have both bagged ap­provals in the US, ex­pand­ing cur­rent mar­ket op­por­tu­ni­ties and open­ing up new

In the lat­est de­vel­op­ment in the “high­ly dy­nam­ic” mol­e­c­u­lar glue space, Mer­ck KGaA has inked a dis­cov­ery agree­ment with C4 Ther­a­peu­tics for two pro­tein de­graders

At the Outsourcing in Clinical Trials conference in New England, Andarix Pharmaceuticals’ CEO shared the uses of social media for improved rare disease trial patient